methotrexate has been researched along with Lassitude in 55 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (5.45) | 18.7374 |
| 1990's | 5 (9.09) | 18.2507 |
| 2000's | 14 (25.45) | 29.6817 |
| 2010's | 19 (34.55) | 24.3611 |
| 2020's | 14 (25.45) | 2.80 |
| Authors | Studies |
|---|---|
| Dimopoulou, D; Maritsi, DN; Spyridis, N; Tsolia, MN; Vartzelis, G | 1 |
| Buch, MH; Burmester, GR; Bykerk, VP; Fernandez-Nebro, A; Huizinga, T; Kameda, H; Praestgaard, A; Tanaka, Y; van Hoogstraten, H | 1 |
| Strand, V | 1 |
| Bartlett, SJ; Bingham, CO; Cella, D; Gold, DA; Gruben, D; Murray, C; van Vollenhoven, R | 1 |
| Aalto, K; Glerup, M; Kautiainen, H; Peltoniemi, S; Rebane, K; Tuomi, AK | 1 |
| Fautrel, B; Haladyj, E; Takeuchi, T; van de Laar, MAFJ; Wang, D; Wu, J | 1 |
| Barton, A; Gwinnutt, JM; Hyrich, KL; Leggett, S; Lunt, M; Verstappen, SMM; Walker-Bone, K | 1 |
| De Cock, D; De Groef, A; Joly, J; Moons, P; Pazmino, S; Stouten, V; Van der Elst, K; Verschueren, P; Vriezekolk, J; Westhovens, R | 1 |
| Biglia, A; Bozzalla Cassione, E; Cavagna, L; Codullo, V; Montecucco, C; Zanframundo, G | 1 |
| Schmidt, WA | 1 |
| Alves-Ferreira, M; Bin, S; Bolze, PA; Devouassoux-Shisheboran, M; Freyer, G; Gladieff, L; Golfier, F; Grazziotin-Soares, D; Hajri, T; Joly, F; Langlois-Jacques, C; Lotz, JP; Massardier, J; Maucort-Boulch, D; Mercier, C; Rousset, P; Roux, A; Villeneuve, L; You, B | 1 |
| Bergman, M; Buch, MH; Camp, HS; Dunlap, K; Friedman, A; Goldschmidt, D; Radominski, SC; Strand, V; Suboticki, JL; Tundia, N; Wells, A | 1 |
| Bartlett, SJ; Bingham, CO; Butanis, AL; Bykerk, VP; Cook, KF; Jones, M; Lyddiatt, A; Orbai, AM; Ruffing, V; Schrandt, MS | 1 |
| Haberstroh, WD; Lenka, A; Triano, MJ; Whelton, SA | 1 |
| Chang, W; Chaudhuri, N; Coker, R; Forrest, I; Ho, LP; Lines, S; Maher, TM; Spencer, LG; Spiteri, M; Thillai, M | 1 |
| Bosse-Henck, A; Brähler, E; Fleischer, M; Hinz, A; Wirtz, H | 1 |
| Boorjian, SA; Brennan, TA; Chen, DY; Dotan, E; Dulaimi, E; Greenberg, RE; Hoffman-Censits, JH; Hudes, GR; Kelly, WK; Kutikov, A; Lallas, CD; Lin, J; Mehrazin, R; Palma, N; Plimack, ER; Ross, EA; Trabulsi, EJ; Uzzo, RG; Viterbo, R; Wong, YN | 1 |
| Jankowski, TA; Jones, DW; Wright, D | 1 |
| Aglipay, MO; Bechard, MA; Duffy, CM; Jurencak, R; Lemieux, JR; Roth, J; Watanabe Duffy, K | 1 |
| Egsmose, EL; Madsen, OR | 1 |
| Agular, B; Gröndal, G; Hansen, I; Jensen, EC; Johansen, P; Juul, L; Lindegaard, HM; Schlemmer, AM | 1 |
| Fatimah, N; Gul, H; Hussain, K; Nasim, A; Niazi, S; Salim, B | 1 |
| D'Amelio, R; Laganà, B; Vinciguerra, M | 1 |
| Bijlsma, JW; Jacobs, JW | 1 |
| Burmester, GR; Combe, B; Coteur, G; Kavanaugh, A; Keystone, EC; Mease, P; Nikaï, E; Strand, V; van Vollenhoven, R | 1 |
| El-Haddad, B; Hammoud, D; Shahouri, S; Shaver, T | 1 |
| Dijkmans, BA; Frings-Dresen, MH; Herenius, MM; Hoving, JL; Lems, WF; Nurmohamed, MT; Raterman, HG; Sluiter, JK; Tak, PP; Voskuyl, AE | 1 |
| Burmester, GR; Coteur, G; Hiepe, F; Khanna, D; Mease, P; Nikaï, E; Schiff, M; Smolen, JS; Strand, V; van Vollenhoven, RF | 1 |
| Amine, B; Hajjaj-Hassouni, N; Ibn Yacoub, Y; Laatiris, A; Wafki, F; Znat, F | 1 |
| Hajjaj-Hassouni, N; Ibn Yacoub, Y; Laatiris, A; Rostom, S | 1 |
| Moosavi, ZB; Radmanesh, M; Rafiei, B; Sina, N | 1 |
| Anastasopoulou, AN; Karagiannidis, GS; Mantzourani, M; Meletis, J; Vaiopoulos, GA | 1 |
| Buchanan, J; Gathany, T; Genovese, MC; Han, C; Hsia, EC; Keystone, EC; Murphy, FT; Parasuraman, S; Rahman, MU; Wu, Z | 1 |
| Aránzazu, M; Cronstein, BN; Feig, JL; Mediero, A; Perez-Aso, M | 1 |
| Cook, J; Lin, CY; Purvis, D | 1 |
| Ameloot, K; De Wever, W; Goffin, K; Palmers, PJ; Voigt, JU | 1 |
| Birbara, CA; Chartash, EK; Fischkoff, SA; Furst, DE; Keystone, EC; Moreland, LW; Teoh, LA; Weinblatt, ME; Weisman, MH | 1 |
| Allen, KA; Balducci, L; Bercu, BB; Cantor, A; Jacobsen, PB; Kumar, N; Minton, S; Riccardi, D | 1 |
| Abu-Saad, HH; Candel, MJ; Courtens, AM; de Jong, N; Schouten, HC | 2 |
| Genovese, MC; Moreland, LW; Sato, R; Singh, A | 1 |
| Babatin, MA; Sanai, FM; Swain, MG | 1 |
| Becker, JC; Blaisdell, B; Cole, JC; Emery, P; Gajria, K; Li, T; Maclean, R; Martin, MC; Russell, AS; Wallenstein, GV | 1 |
| Jensen, AB; Johansson, A; Mehlsen, M; Paulsen, K; von der Maase, H; Zachariae, R | 1 |
| Abu-Saad, HH; Courtens, AM; de Jong, N; Kester, AD; Schouten, HC | 1 |
| Käser, L; Kolyvanos Naumann, U; Nigg, C; Vetter, W | 1 |
| Engelsman, E; Hanewald, GJ; Linssen, AC; van Benthem, J; Van Dam, FS | 1 |
| Arndt, KA; Momtaz, K; Parrish, JA; Paul, BS; Stern, RS | 1 |
| Halla, JT; Hardin, JG | 1 |
| Kadin, ME; Sajjadian, A; Vonderheid, EC | 1 |
| Fifield, J; McQuillan, J; Reisine, S; Tennen, H | 1 |
| Karemaker, JM; Lenders, JW; Timmers, HJ; Wieling, W | 1 |
| Gao, R; King, ME; Mori, M; Nail, LM; Schwartz, AL | 1 |
| Kaplan, MM; Knox, TA | 1 |
| Hattori, T; Jinushi, K; Kim, R; Niimoto, M; Saeki, K; Saeki, T; Toi, M; Yanagawa, E; Yoshinaka, K | 1 |
3 review(s) available for methotrexate and Lassitude
| Article | Year |
|---|---|
[Inflammatory Muscle Pain: Polymyalgia Rheumatica with or without Large Vessel Vasculitis].
Topics: Aged; Antibodies, Monoclonal, Humanized; Blindness; Diagnosis, Differential; Fatigue; Female; Giant Cell Arteritis; Humans; Methotrexate; Polymyalgia Rheumatica; Prednisolone; Stroke; Ultrasonography; Vasculitis | 2020 |
Clinical inquiry. What treatments relieve arthritis and fatigue associated with systemic lupus erythematosus?
Topics: Antirheumatic Agents; Arthritis; Disease Management; Exercise Therapy; Fatigue; Fish Oils; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Methotrexate; Randomized Controlled Trials as Topic; Self Care; Symptom Assessment; Treatment Outcome | 2014 |
Modulation of T-cell co-stimulation in rheumatoid arthritis: clinical experience with abatacept.
Topics: Abatacept; Antirheumatic Agents; Arthritis, Rheumatoid; Fatigue; Humans; Immunoconjugates; Methotrexate; Pain; Quality of Life; Radiography; Sleep; Stimulation, Chemical; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2009 |
15 trial(s) available for methotrexate and Lassitude
| Article | Year |
|---|---|
The impact of tofacitinib on fatigue, sleep, and health-related quality of life in patients with rheumatoid arthritis: a post hoc analysis of data from Phase 3 trials.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Fatigue; Humans; Methotrexate; Piperidines; Pyrimidines; Pyrroles; Quality of Life; Sleep; Treatment Outcome | 2022 |
Relative Impact of Pain and Disease Activity on Improvements in Fatigue: Results From 2 Baricitinib Phase 3 Clinical Trials.
Topics: Adalimumab; Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Drug Therapy, Combination; Fatigue; Humans; Methotrexate; Pain; Treatment Outcome | 2023 |
One in five patients with rapidly and persistently controlled early rheumatoid arthritis report poor well-being after 1 year of treatment.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Fatigue; Female; Humans; Male; Methotrexate; Middle Aged; Pain; Pain Measurement; Patient Reported Outcome Measures; Quality of Life; Recovery of Function; Severity of Illness Index; Treatment Outcome | 2020 |
Avelumab in Patients With Gestational Trophoblastic Tumors With Resistance to Single-Agent Chemotherapy: Cohort A of the TROPHIMMUN Phase II Trial.
Topics: Adult; Antibiotics, Antineoplastic; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents, Immunological; Chorionic Gonadotropin; Dactinomycin; Drug Resistance, Neoplasm; Fatigue; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Injection Site Reaction; Methotrexate; Middle Aged; Nausea; Pregnancy; Retreatment; Vomiting; Young Adult | 2020 |
Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY.
Topics: Activities of Daily Living; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Efficiency; Fatigue; Female; Heterocyclic Compounds, 3-Ring; Humans; Janus Kinase Inhibitors; Least-Squares Analysis; Male; Methotrexate; Middle Aged; Pain Measurement; Patient Reported Outcome Measures; Quality of Life; Work | 2021 |
Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Fatigue; Female; Filgrastim; Gene Expression Profiling; Granulocyte Colony-Stimulating Factor; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Polyethylene Glycols; Prospective Studies; Protective Agents; Recombinant Proteins; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2014 |
Doubling the single-dose infusion rate of tocilizumab in rheumatoid arthritis is safe and efficacious.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Drug Hypersensitivity; Edema; Fatigue; Female; Flushing; Glucocorticoids; Headache; Humans; Hypercholesterolemia; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Nasopharyngitis; Neutropenia; Treatment Outcome; Tumor Necrosis Factor-alpha | 2016 |
Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled
Topics: Activities of Daily Living; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Certolizumab Pegol; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Humans; Immunoglobulin Fab Fragments; Male; Methotrexate; Middle Aged; Pain; Pain Measurement; Polyethylene Glycols; Quality of Life; Recovery of Function; Severity of Illness Index | 2009 |
Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Certolizumab Pegol; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Epidemiologic Methods; Fatigue; Female; Humans; Immunoglobulin Fab Fragments; Male; Methotrexate; Middle Aged; Pain; Pain Measurement; Polyethylene Glycols; Quality of Life; Treatment Outcome | 2011 |
Weekly vs. daily administration of oral methotrexate (MTX) for generalized plaque psoriasis: a randomized controlled clinical trial.
Topics: Adolescent; Adult; Aged; Blood Cell Count; Blood Urea Nitrogen; Creatinine; Dermatologic Agents; Drug Administration Schedule; Fatigue; Female; Headache; Humans; Liver Function Tests; Male; Methotrexate; Middle Aged; Nausea; Psoriasis; Severity of Illness Index; Treatment Outcome; Vomiting; Young Adult | 2011 |
Effect of golimumab on patient-reported outcomes in rheumatoid arthritis: results from the GO-FORWARD study.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cross-Over Studies; Drug Therapy, Combination; Fatigue; Female; Health Status; Humans; Male; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Patient Satisfaction; Quality of Life; Recovery of Function; Self Report; Surveys and Questionnaires; Treatment Outcome | 2012 |
Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.
Topics: Adalimumab; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Collagenases; Combined Modality Therapy; Enzyme Precursors; Fatigue; Female; Humans; Male; Matrix Metalloproteinase 1; Metalloendopeptidases; Methotrexate; Middle Aged; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha | 2003 |
Effect of etanercept on fatigue in patients with recent or established rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Etanercept; Fatigue; Female; Humans; Immunoglobulin G; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Time Factors | 2006 |
Abatacept improves both the physical and mental health of patients with rheumatoid arthritis who have inadequate response to methotrexate treatment.
Topics: Abatacept; Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Fatigue; Female; Humans; Immunoconjugates; Longitudinal Studies; Male; Methotrexate; Middle Aged; Quality of Life; Sickness Impact Profile | 2007 |
Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy.
Topics: Activities of Daily Living; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Exercise Therapy; Fatigue; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Treatment Outcome | 2001 |
37 other study(ies) available for methotrexate and Lassitude
| Article | Year |
|---|---|
Safety and tolerability of the COVID-19 messenger RNA vaccine in adolescents with juvenile idiopathic arthritis treated with tumor necrosis factor inhibitors.
Topics: Adalimumab; Adolescent; Antirheumatic Agents; Arthralgia; Arthritis, Juvenile; BNT162 Vaccine; COVID-19; Disease Progression; Etanercept; Fatigue; Female; Headache; Humans; Injection Site Reaction; Male; Methotrexate; Myalgia; SARS-CoV-2; Tumor Necrosis Factor Inhibitors; Young Adult | 2022 |
Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Fatigue; Humans; Methotrexate; Pain; Treatment Outcome | 2022 |
Patient-reported outcomes and realistic clinical endpoints for JAK inhibitors in rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials, Phase III as Topic; Fatigue; Humans; Janus Kinase Inhibitors; Methotrexate; Patient Reported Outcome Measures; Randomized Controlled Trials as Topic; Treatment Outcome | 2022 |
Abdominal pain in Finnish young adults with juvenile idiopathic arthritis.
Topics: Abdominal Pain; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Juvenile; Fatigue; Female; Finland; Follow-Up Studies; Humans; Methotrexate; Quality of Life; Sulfasalazine; Young Adult | 2022 |
Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis.
Topics: Absenteeism; Adult; Age Factors; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Fatigue; Female; Humans; Male; Methotrexate; Middle Aged; Presenteeism; Psychological Distress; Sex Factors; Sick Leave; Time Factors; Unemployment; Young Adult | 2020 |
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Laboratory Techniques; Cohort Studies; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Cyclosporine; Diarrhea; Dysgeusia; Dyspnea; Fatigue; Female; Fever; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Incidence; Intensive Care Units; Italy; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Olfaction Disorders; Pandemics; Pneumonia, Viral; Prednisone; Respiratory Distress Syndrome; SARS-CoV-2; Telemedicine | 2020 |
Patients and clinicians define symptom levels and meaningful change for PROMIS pain interference and fatigue in RA using bookmarking.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Fatigue; Female; Humans; Male; Methotrexate; Middle Aged; Pain Measurement; Patient Reported Outcome Measures; Severity of Illness Index; Symptom Assessment; Treatment Outcome | 2021 |
Relapsed granulomatosis with polyangiitis with panhypopituitarism.
Topics: Adrenal Insufficiency; Androgens; Diabetes Insipidus; Fatigue; Glucocorticoids; Granulomatosis with Polyangiitis; Hormone Replacement Therapy; Humans; Hypogonadism; Hypopituitarism; Hypothyroidism; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Pituitary Diseases; Pituitary Gland; Recurrence; Rhinitis; Sella Turcica; Sinusitis; Testosterone; Thyroxine; Weight Loss | 2021 |
Sarcoidosis in the UK: insights from British Thoracic Society registry data.
Topics: Bronchoalveolar Lavage; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Fatigue; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lung; Male; Methotrexate; Middle Aged; Quality of Life; Registries; Retrospective Studies; Sarcoidosis, Pulmonary; Tomography, X-Ray Computed; United Kingdom | 2019 |
Factors associated with fatigue in sarcoidosis.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Cohort Studies; Fatigue; Female; Germany; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prednisolone; Risk Factors; Sarcoidosis; Sleep Apnea Syndromes; Surveys and Questionnaires | 2014 |
Procedural pain and patient-reported side effects with weekly injections of subcutaneous methotrexate in children with rheumatic disorders.
Topics: Adolescent; Anorexia; Antirheumatic Agents; Child; Child, Preschool; Cohort Studies; Fatigue; Female; Humans; Incidence; Injections, Subcutaneous; Male; Methotrexate; Nausea; Pain; Pain Measurement; Prospective Studies; Retrospective Studies; Rheumatic Diseases; Vomiting | 2014 |
Interplay between patient global assessment, pain, and fatigue and influence of other clinical disease activity measures in patients with active rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Denmark; Fatigue; Female; Humans; Male; Methotrexate; Middle Aged; Pain; Pain Measurement; Prednisolone; Registries; Reproducibility of Results; Rheumatology; Severity of Illness Index; Visual Analog Scale | 2015 |
Frequency of methotrexate intolerance in rheumatoid arthritis patients using methotrexate intolerance severity score (MISS questionnaire).
Topics: Abdominal Pain; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Fatigue; Female; Humans; Methotrexate; Nausea; Surveys and Questionnaires; Vomiting | 2016 |
Methotrexate: still the anchor drug in RA treatment.
Topics: Administration, Oral; Antirheumatic Agents; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Drug Monitoring; Evidence-Based Medicine; Fatigue; Humans; Methotrexate; Netherlands; Tumor Necrosis Factor-alpha | 2009 |
Malignancy-associated multicentric reticulohistiocytosis.
Topics: Antihypertensive Agents; Antineoplastic Agents; Arthralgia; Atenolol; Combined Modality Therapy; Drug Therapy, Combination; Fatigue; Female; Hand; Histiocytosis, Non-Langerhans-Cell; Humans; Hydrochlorothiazide; Hypertension; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasms, Squamous Cell; Prednisone; Radiography; Weight Loss | 2011 |
Improvement of work ability, quality of life, and fatigue in patients with rheumatoid arthritis treated with adalimumab.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Disability Evaluation; Efficiency; Fatigue; Female; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Quality of Life; Tumor Necrosis Factor Inhibitors | 2010 |
Fatigue and severity of rheumatoid arthritis in Moroccan patients.
Topics: Adult; Antirheumatic Agents; Arthralgia; Arthritis, Rheumatoid; Disability Evaluation; Educational Status; Fatigue; Female; Health Status; Humans; Male; Methotrexate; Middle Aged; Morocco; Quality of Life; Radiography; Severity of Illness Index; Sjogren's Syndrome; Smoking; Social Class; Surveys and Questionnaires; Treatment Outcome | 2012 |
Primary Sjögren's syndrome in Moroccan patients: characteristics, fatigue and quality of life.
Topics: Adult; Aged; Antidepressive Agents; Antirheumatic Agents; Cross-Sectional Studies; Depression; Disability Evaluation; Fatigue; Female; Humans; Male; Methotrexate; Middle Aged; Morocco; Prevalence; Quality of Life; Retrospective Studies; Severity of Illness Index; Sjogren's Syndrome; Surveys and Questionnaires; Treatment Outcome | 2012 |
Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate.
Topics: Aged; Amphotericin B; Antiprotozoal Agents; Arthritis, Rheumatoid; Fatigue; Female; Fluorescent Antibody Technique, Indirect; Hepatomegaly; Humans; Immunosuppressive Agents; Leishmania; Leishmaniasis, Visceral; Methotrexate; Splenomegaly; Tomography, X-Ray Computed | 2012 |
Adenosine A2A receptor and TNF-α regulate the circadian machinery of the human monocytic THP-1 cells.
Topics: Adenosine; ARNTL Transcription Factors; Arthritis, Rheumatoid; Cell Line; Circadian Clocks; Circadian Rhythm; CLOCK Proteins; Cryptochromes; Fatigue; Humans; Inflammation; Interleukin-1; Interleukin-10; Methotrexate; Monocytes; Period Circadian Proteins; Phenethylamines; Receptor, Adenosine A2A; RNA, Messenger; Tumor Necrosis Factor-alpha | 2013 |
Febrile ulceronecrotic Mucha-Habermann disease: a case with systemic symptoms managed with subcutaneous methotrexate.
Topics: Arthritis; Child; Dermatologic Agents; Fatigue; Herpes Simplex; Humans; Male; Methotrexate; Pityriasis Lichenoides | 2012 |
An echocardiographic finding leading to the diagnosis of giant cell arteritis.
Topics: Aged; Echocardiography, Transesophageal; Fatigue; Follow-Up Studies; Giant Cell Arteritis; Humans; Methotrexate; Methylprednisolone; Positron-Emission Tomography; Risk Assessment; Syncope; Treatment Outcome; Weight Loss | 2013 |
Fatigue, weight gain, lethargy and amenorrhea in breast cancer patients on chemotherapy: is subclinical hypothyroidism the culprit?
Topics: Adult; Aged; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Estradiol; Fatigue; Female; Fluorouracil; Humans; Hypothyroidism; Methotrexate; Middle Aged; Prospective Studies; Sleep Stages; Thyroxine; Weight Gain | 2004 |
Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease Progression; Doxorubicin; Fatigue; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Prevalence; Prospective Studies; Quality of Life | 2004 |
Course of mental fatigue and motivation in breast cancer patients receiving adjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cognition Disorders; Cyclophosphamide; Depression; Fatigue; Female; Fluorouracil; Humans; Mastectomy; Mastectomy, Segmental; Methotrexate; Middle Aged; Motivation; Prospective Studies; Quality of Life | 2005 |
Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Cholagogues and Choleretics; Drug Administration Schedule; Enzyme Inhibitors; Fatigue; Female; gamma-Glutamyltransferase; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Methotrexate; Middle Aged; Pruritus; Rifampin; Treatment Outcome; Ursodeoxycholic Acid | 2006 |
Chemotherapy-induced nausea, vomiting, and fatigue--the role of individual differences related to sensory perception and autonomic reactivity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Arousal; Autonomic Nervous System; Awareness; Biological Availability; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Fatigue; Female; Fluorouracil; Humans; Individuality; Methotrexate; Middle Aged; Nausea; Personality Inventory; Risk Factors; Sensory Thresholds; Sick Role; Somatoform Disorders; Statistics as Topic; Vomiting | 2007 |
[Results of a study on fatigue in breast cancer patients receiving adjuvant chemotherapy: the first four days after treatment are the worst].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Nursing Research; Cohort Studies; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Fatigue; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Netherlands | 2007 |
[Giant cell arteritis].
Topics: Aged; Blood Sedimentation; Diagnosis, Differential; Diagnostic Tests, Routine; Fatigue; Female; Giant Cell Arteritis; Glucocorticoids; Headache; Humans; Methotrexate; Prednisone; Ultrasonography, Doppler, Color; Vision Disorders | 2007 |
Life with cytostatic drugs.
Topics: Activities of Daily Living; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Fatigue; Feeding and Eating Disorders; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Patient Acceptance of Health Care; Vincristine | 1980 |
Combined methotrexate--ultraviolet B therapy in the treatment of psoriasis.
Topics: Adult; Erythema; Fatigue; Female; Humans; Male; Methotrexate; Middle Aged; Nausea; Photochemotherapy; Psoriasis; PUVA Therapy | 1982 |
Underrecognized postdosing reactions to methotrexate in patients with rheumatoid arthritis.
Topics: Administration, Oral; Arthralgia; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Fatigue; Female; Humans; Infusions, Parenteral; Male; Methotrexate; Middle Aged; Muscular Diseases; Pain; Time Factors | 1994 |
Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anemia; Antimetabolites, Antineoplastic; Aspartate Aminotransferases; Dermatologic Agents; Diarrhea; Drug Administration Schedule; Fatigue; Female; Follow-Up Studies; Humans; Ki-1 Antigen; Liver Cirrhosis; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Peripheral; Lymphomatoid Papulosis; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Nausea; Remission Induction; Skin Diseases; Skin Neoplasms; Weight Loss | 1996 |
Depression and the long-term risk of pain, fatigue, and disability in patients with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Depression; Disability Evaluation; Fatigue; Humans; Methotrexate; Pain; Prednisone; Risk Factors; Severity of Illness Index; Time Factors | 1998 |
Baroreflex failure following radiation therapy for nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Baroreflex; Blood Pressure; Combined Modality Therapy; Cyclophosphamide; Fatigue; Head and Neck Neoplasms; Heart Rate; Humans; Hypotension, Orthostatic; Lymphatic Metastasis; Male; Methotrexate; Nasopharyngeal Neoplasms; Pain; Posture; Radiotherapy; Remission Induction; Valsalva Maneuver; Vincristine | 1999 |
Treatment of primary biliary cirrhosis with low-dose weekly methotrexate.
Topics: Adult; Alkaline Phosphatase; Bilirubin; Biopsy; Cholesterol; Drug Evaluation; Fatigue; Female; Follow-Up Studies; Humans; Leukopenia; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Methotrexate; Middle Aged; Pruritus; Thrombocytopenia; Transaminases | 1991 |
[Combination chemotherapy of CPM-MTX-5-FU in non-resectable and recurrent cancer patients].
Topics: Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Drug Evaluation; Fatigue; Fluorouracil; Humans; Leukopenia; Methotrexate; Nausea; Neoplasm Recurrence, Local; Neoplasms; Remission Induction; Stomach Neoplasms | 1989 |